| Followers | 245 |
| Posts | 4746 |
| Boards Moderated | 0 |
| Alias Born | 11/29/2016 |
Thursday, September 04, 2025 7:33:31 PM
This tickers PA is extremely predictable, I think I've been wrong one time, and it was back on 7/23/25 when I thought it was on the verge of breaking out past .0025. Other than that, one-time I've been spot on with its PA. It printed a .00125 today cleaning out the remaining .0013's. I fully expect the 12's to get cleared out as well. .0012 holds much better support, and unless the worthless management wants another full reset back to .0006 again, which I also called it last year when it was still in the high teens that we'd see a full reset to .0006. I do however think they have a interesting product one that should easily create shareholder value. The main problem is the management/ and PR department or horrible and haven't a clue how to run a company in the OTC to generate liquidity. MOVE the TICKER and everyone in the broke OTC comes running. These guys haven't got a clue, and its frustrating to see. This ticker is in no man's land trading here. Any moment a good PR could send it moving higher, or it could just continue to drift lower as its doing. GL
Recent ADHC News
- American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA • Newsfile • 04/01/2026 12:30:00 PM
- American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division • Newsfile • 01/06/2026 02:00:00 PM
- GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program • Newsfile • 11/25/2025 02:00:00 PM
- GlucoGuard Receives $43 Million Enterprise Valuation From Prominent CFA Led Harbinger Research • Newsfile • 11/04/2025 02:00:00 PM
- American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund • Newsfile • 10/16/2025 01:00:00 PM
- GlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep Study • Newsfile • 10/14/2025 10:00:00 AM
